Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline

[ad_1] Eli Lilly will spend $4.5 billion to build a center aimed at finding better ways…

Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market

[ad_1] An Eli Lilly & Co. Zepbound injection pen, March 28, 2024. Bloomberg | Bloomberg |…

Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar

[ad_1] Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked…

Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says

[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York…

Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply

[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York…

Newseum Global